联系客服

301331 深市 恩威医药


首页 公告 恩威医药:2023年度非经营性资金占用及其他关联资金往来情况汇总表

恩威医药:2023年度非经营性资金占用及其他关联资金往来情况汇总表

公告日期:2024-04-22

恩威医药:2023年度非经营性资金占用及其他关联资金往来情况汇总表 PDF查看PDF原文
附件一

                                                                        2023年度非经营性资金占用及其他关联资金往来情况汇总表

上市公司名称:恩威医药股份有限公司                                                                                                                                                                                                        单位:万元

    非经营性资金占用                资金占用方名称            占用方与上市公司的  上市公司核算的会计科目  2023年期初占用资金  2023年度占用累计发  2023年度占用资金的  2023年度偿还累计发  2023年期末占用资金    占用形成原因        占用性质
                                                                    关联关系                                        余额        生金额(不含利息)    利息(如有)          生金额              余额

 控股股东、实际控制人及其

        附属企业

          小计                            -                            -                      -                              -                  -                  -                  -                  -        -                  -

 前控股股东、实际控制人及

      其附属企业

          小计                            -                            -                      -                              -                  -                  -                  -                  -        -                  -

          总计                            -                            -                      -                              -                  -                  -                  -                  -        -                  -

    其它关联资金往来                资金往来方名称            往来方与上市公司的  上市公司核算的会计科目  2023年期初往来资金  2023年度往来累计发  2023年度往来资金的  2023年度偿还累计发  2023年期末往来资金    往来形成原因        往来性质
                                                                    关联关系                                        余额        生金额(不含利息)    利息(如有)          生金额              余额

 控股股东、实际控制人及其

        附属企业

          小计                            -                            -                      -                              -                  -                  -                  -                  -          -                  -

                          成都恩威科技有限公司                全资子公司          其他应收款                            26.18                                                        26.18                  -  科技垫付款        非经营性往来

 上市公司的子公司及其附属  四川恩威制药有限公司                全资子公司          其他应收款                          32,869.06            66,967.61                                58,599.20            41,237.48  借款              非经营性往来

          企业            恩威(郑州)医药科技有限公司        全资子公司          其他应收款                                              10,000.00                                                    10,000.00  借款              非经营性往来

                          四川恩威制药有限公司                全资子公司          其他反映占用实质科目                15,000.00                                                    15,000.00                  -  利润分配          非经营性往来

          小计                            -                            -                      -                        47,895.24            76,967.61                  -            73,625.37            51,237.48        -                  -

                          吉林恩威锐邦药业有限公司              参股公司          应收账款                                5.86              130.95                                  136.05                0.76  销售商品          经营性往来

 其他关联人及其附属企业

          小计                            -                            -                      -                            5.86              130.95                  -              136.05                0.76        -                  -

          总计                            -                            -                      -                        47,901.10            77,098.56                  -            73,761.42            51,238.24        -                  -

企业负责人:薛永江                                                                  主管会计工作的负责人:  胡大伟                                                                          会计机构负责人:    甯慧

[点击查看PDF原文]